Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SSBP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PCNP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | KPTN | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | KRTAP9-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | DLG5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | IDH2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PPIG | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | MTPAP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | F2RL3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZBTB45 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |